7YVF
Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH027 Fab
7YVF の概要
エントリーDOI | 10.2210/pdb7yvf/pdb |
EMDBエントリー | 34125 |
分子名称 | TH027 Fab light chain, TH027 Fab heavy chain, Spike glycoprotein (3 entities in total) |
機能のキーワード | covid-19, spike glycoprotein, virus, viral protein, antiviral protein-viral protein complex, antiviral protein/viral protein |
由来する生物種 | Homo sapiens 詳細 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 167900.15 |
構造登録者 | |
主引用文献 | Guo, Y.,Zhang, G.,Yang, Q.,Xie, X.,Lu, Y.,Cheng, X.,Wang, H.,Liang, J.,Tang, J.,Gao, Y.,Shang, H.,Dai, J.,Shi, Y.,Zhou, J.,Zhou, J.,Guo, H.,Yang, H.,Qi, J.,Liu, L.,Ma, S.,Zhang, B.,Huo, Q.,Xie, Y.,Wu, J.,Dong, F.,Zhang, S.,Lou, Z.,Gao, Y.,Song, Z.,Wang, W.,Sun, Z.,Yang, X.,Xiong, D.,Liu, F.,Chen, X.,Zhu, P.,Wang, X.,Cheng, T.,Rao, Z. Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. Nat Commun, 14:3537-3537, 2023 Cited by PubMed Abstract: The SARS-CoV-2 Omicron variant evades most currently approved neutralizing antibodies (nAbs) and caused drastic decrease of plasma neutralizing activity elicited by vaccination or prior infection, urging the need for the development of pan-variant antivirals. Breakthrough infection induces a hybrid immunological response with potentially broad, potent and durable protection against variants, therefore, convalescent plasma from breakthrough infection may provide a broadened repertoire for identifying elite nAbs. We performed single-cell RNA sequencing (scRNA-seq) and BCR sequencing (scBCR-seq) of B cells from BA.1 breakthrough-infected patients who received 2 or 3 previous doses of inactivated vaccine. Elite nAbs, mainly derived from the IGHV2-5 and IGHV3-66/53 germlines, showed potent neutralizing activity across Wuhan-Hu-1, Delta, Omicron sublineages BA.1 and BA.2 at picomolar NT values. Cryo-EM analysis revealed diverse modes of spike recognition and guides the design of cocktail therapy. A single injection of paired antibodies cocktail provided potent protection in the K18-hACE2 transgenic female mouse model of SARS-CoV-2 infection. PubMed: 37322000DOI: 10.1038/s41467-023-39267-x 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (3.4 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
